Abstract In 2011, the National Institute on Aging and Alzheimer's Association created separate diagnostic recommendations for the preclinical, mild cognitive impairment, and dem...
The pathophysiological process of Alzheimer's disease (AD) is thought to begin many years before the diagnosis of AD dementia. This long “preclinical” phase of AD would provide ...
These data suggest that mild cognitive impairment may be the earliest clinical manifestation of common age-related neurologic diseases.
Biomarkers have become an essential component of Alzheimer disease (AD) research and because of the pervasiveness of AD pathology in the elderly, the same biomarkers are used in...
Mild age-related decline in cognitive function is mainly due to the neuropathologic lesions traditionally associated with dementia.
h-index: Number of publications with at least h citations each.